These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 6518244)

  • 1. The application of a sequential procedure with elimination as a method for the screening for metabolic diseases.
    Geertsema JC; Reinecke CJ
    Biometrics; 1984 Sep; 40(3):663-73. PubMed ID: 6518244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic disease in mental retardation: a study in Texas.
    Farrell G; Johnson R; Fabre L; Farmer R; Pellizzari E; Stephenson M
    Birth Defects Orig Artic Ser; 1971 May; 7(6):94-7. PubMed ID: 5173196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between glomerular filtration rate and the prevalence of metabolic abnormalities: results from the Third National Health and Nutrition Examination Survey (NHANES III).
    Clase CM; Kiberd BA; Garg AX
    Nephron Clin Pract; 2007; 105(4):c178-84. PubMed ID: 17347576
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contingent screening for Down syndrome is an efficient alternative to non-disclosure sequential screening.
    Wright D; Bradbury I; Benn P; Cuckle H; Ritchie K
    Prenat Diagn; 2004 Oct; 24(10):762-6. PubMed ID: 15503281
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Statistical evaluation of screening programs].
    Nurminen M
    Duodecim; 1974; 90(22):1526-34. PubMed ID: 4452325
    [No Abstract]   [Full Text] [Related]  

  • 6. Modelling of classification rules on metabolic patterns including machine learning and expert knowledge.
    Baumgartner C; Böhm C; Baumgartner D
    J Biomed Inform; 2005 Apr; 38(2):89-98. PubMed ID: 15796999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selecting a screening cut-off point or diagnostic criterion for comparing prevalences of disease.
    Brownie C; Habicht JP
    Biometrics; 1984 Sep; 40(3):675-84. PubMed ID: 6518245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic studies in older mentally retarded patients: significance of metabolic testing and correlation with the clinical phenotype.
    Van Buggenhout GJ; Trijbels JM; Wevers R; Trommelen JC; Hamel BC; Brunner HG; Fryns JP
    Genet Couns; 2001; 12(1):1-21. PubMed ID: 11332972
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First- and second-trimester evaluation of risk for Down syndrome.
    Ball RH; Caughey AB; Malone FD; Nyberg DA; Comstock CH; Saade GR; Berkowitz RL; Gross SJ; Dugoff L; Craigo SD; Timor-Tritsch IE; Carr SR; Wolfe HM; Emig D; D'Alton ME;
    Obstet Gynecol; 2007 Jul; 110(1):10-7. PubMed ID: 17601890
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health fair screening: the clinical utility of the comprehensive metabolic profile.
    Alpert JP; Greiner A; Hall S
    Fam Med; 2004; 36(7):514-9. PubMed ID: 15243834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A method for sequential analysis of survival data with nonproportional hazards.
    Sooriyarachchi MR; Whitehead J
    Biometrics; 1998 Sep; 54(3):1072-84. PubMed ID: 9750253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An age-adjusted bootstrap-based Poly-k test.
    Moon H; Ahn H; Kodell RL
    Stat Med; 2005 Apr; 24(8):1233-44. PubMed ID: 15573413
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Item reduction in a scale for screening.
    Liu X; Jin Z
    Stat Med; 2007 Oct; 26(23):4311-27. PubMed ID: 17357995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neurometabolic diagnosis of mental retardation].
    García L
    Rev Neurol; 1997 May; 25(141):765-8. PubMed ID: 9206607
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The multi-institutional validation of the new screening index for physical child abuse.
    Chang DC; Knight VM; Ziegfeld S; Haider A; Paidas C
    J Pediatr Surg; 2005 Jan; 40(1):114-9. PubMed ID: 15868569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of one-sample two-sided sequential t-tests for application in epidemiological studies.
    van der Tweel I; Kaaks R; van Noord PA
    Stat Med; 1996 Dec; 15(24):2781-95. PubMed ID: 8981686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined ultrasound biometry, serum markers and age for Down syndrome risk estimation.
    Bahado-Singh RO; Oz AU; Gomez K; Hunter D; Copel J; Baumgarten A; Mahoney MJ
    Ultrasound Obstet Gynecol; 2000 Mar; 15(3):199-204. PubMed ID: 10846774
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening program as an aid to diagnosis of metabolic problems.
    Gourley B
    Manit Med Rev; 1966 Jan; 46(1):30. PubMed ID: 5902731
    [No Abstract]   [Full Text] [Related]  

  • 19. A new method for the classification of invasive cervical cancer screening histories.
    Bagnall H; Pearmain P; Clare J; Lawrence G
    J Med Screen; 2006; 13(3):137-47. PubMed ID: 17007655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel design for estimating relative accuracy of screening tests when complete disease verification is not feasible.
    Alonzo TA; Kittelson JM
    Biometrics; 2006 Jun; 62(2):605-12. PubMed ID: 16918926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.